CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

09 مايو 2024 16:05:01 بحسب Nasdaq GlobeNewswire

Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference

08 مايو 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024

30 أبريل 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors

16 أبريل 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

02 أبريل 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer

18 مارس 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

12 مارس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

12 مارس 2024 09:45:16 بحسب NetDania Notify

NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

11 مارس 2024 12:16:48 بحسب NetDania Notify

NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

08 مارس 2024 09:45:23 بحسب NetDania Notify

NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

07 مارس 2024 09:45:03 بحسب NetDania Notify

NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

06 مارس 2024 12:23:17 بحسب NetDania Notify

Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024

29 فبراير 2024 07:05:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering

07 فبراير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD

14 ديسمبر 2023 07:05:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

13 نوفمبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference

08 نوفمبر 2023 07:05:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting

07 نوفمبر 2023 16:20:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting

02 نوفمبر 2023 07:05:00 بحسب Nasdaq GlobeNewswire

Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD

01 نوفمبر 2023 07:05:00 بحسب Nasdaq GlobeNewswire